Trademark Overview
On Friday, April 11, 2025, a trademark application was filed for ASKELLYN with the United States Patent and Trademark Office. The USPTO has given the ASKELLYN trademark a serial number of 99132705. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 11, 2025. This trademark is owned by Ignition Communications Inc.. The ASKELLYN trademark is filed in the Personal, Legal & Social Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Educational and entertainment services, namely, providing motivational speaking services in the field of cancer survival, emotional support, and resources for cancer patients and their families, and non-medical information relating to oncology diseases; Providing a website featuring blogs and non-downloadable publications in the nature of articles, videos, podcasts, book excerpts, and opinion pieces in the field(s) of cancer survival, emotional support, and resources for cancer patients and their families, and non-medical information relating to oncology diseases; Entertainment services, namely, providing podcasts in the field of cancer survival, emotional support, and resources for cancer patients and their families, and non-medical information relating to oncology diseases; Educational services, namely, conducting classes, seminars, conferences, workshops, retreats, camps and field trips in the field of cancer survival, emotional support, and resources for cancer patients and their f...
Providing emotional support to cancer patients and their families via interactive online forums; Providing a website via a global computer network featuring supportive personal stories on the subjects of health, cancer, cancer recovery and survival
Providing temporary use of online non-downloadable computer chatbot software for simulating conversations; Providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for simulating conversations and providing non-medical information relating to oncology diseases
